XML 59 R35.htm IDEA: XBRL DOCUMENT v2.4.1.9
Description of Business and Significant Accounting Policies (Details Narrative) (USD $)
12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Cash and Cash Equivalents      
Cash and cash equivalents $ 558,541us-gaap_CashAndCashEquivalentsAtCarryingValue $ 456,374us-gaap_CashAndCashEquivalentsAtCarryingValue $ 546,143us-gaap_CashAndCashEquivalentsAtCarryingValue
Restricted certificate of deposit 225,315us-gaap_RestrictedCashAndCashEquivalents 204,222us-gaap_RestrictedCashAndCashEquivalents  
Impairment of Long-Lived Assets      
Impairment of long-lived assets, approximate carrying value 0us-gaap_GainLossOnDispositionOfAssets1 307,402us-gaap_GainLossOnDispositionOfAssets1  
Research and Development      
Research and development 464,206us-gaap_ResearchAndDevelopmentExpense 706,048us-gaap_ResearchAndDevelopmentExpense  
Share-Based Compensation      
Equity based compensation $ 243,683us-gaap_ShareBasedCompensation $ 348,506us-gaap_ShareBasedCompensation  
Accounts Receivable      
Revenue Recognition      
Two entities representing more than 10% of revenues and accounts receivable 40.00%us-gaap_ConcentrationRiskPercentage1
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= us-gaap_AccountsReceivableMember
48.00%us-gaap_ConcentrationRiskPercentage1
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= us-gaap_AccountsReceivableMember
 
Sales Revenue      
Revenue Recognition      
Two entities representing more than 10% of revenues and accounts receivable 36.00%us-gaap_ConcentrationRiskPercentage1
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= us-gaap_SalesRevenueProductLineMember
44.00%us-gaap_ConcentrationRiskPercentage1
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= us-gaap_SalesRevenueProductLineMember